AR016448A1 - Bifenilsulfonilcianamidas y preparacion farmaceutica que las contiene. - Google Patents

Bifenilsulfonilcianamidas y preparacion farmaceutica que las contiene.

Info

Publication number
AR016448A1
AR016448A1 ARP990100482A ARP990100482A AR016448A1 AR 016448 A1 AR016448 A1 AR 016448A1 AR P990100482 A ARP990100482 A AR P990100482A AR P990100482 A ARP990100482 A AR P990100482A AR 016448 A1 AR016448 A1 AR 016448A1
Authority
AR
Argentina
Prior art keywords
alkyl
independently
substituted
worth
represent
Prior art date
Application number
ARP990100482A
Other languages
English (en)
Spanish (es)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR016448A1 publication Critical patent/AR016448A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ARP990100482A 1998-02-04 1999-02-05 Bifenilsulfonilcianamidas y preparacion farmaceutica que las contiene. AR016448A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19804251A DE19804251A1 (de) 1998-02-04 1998-02-04 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Publications (1)

Publication Number Publication Date
AR016448A1 true AR016448A1 (es) 2001-07-04

Family

ID=7856542

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100482A AR016448A1 (es) 1998-02-04 1999-02-05 Bifenilsulfonilcianamidas y preparacion farmaceutica que las contiene.

Country Status (19)

Country Link
US (1) US6369069B1 (enExample)
EP (1) EP1053224B1 (enExample)
JP (1) JP4464559B2 (enExample)
KR (1) KR100595353B1 (enExample)
CN (1) CN1231465C (enExample)
AR (1) AR016448A1 (enExample)
AT (1) ATE222584T1 (enExample)
AU (1) AU758154B2 (enExample)
BR (1) BR9907667A (enExample)
CA (1) CA2319555A1 (enExample)
DE (2) DE19804251A1 (enExample)
DK (1) DK1053224T3 (enExample)
ES (1) ES2182504T3 (enExample)
HU (1) HU224618B1 (enExample)
PL (1) PL342453A1 (enExample)
PT (1) PT1053224E (enExample)
RU (1) RU2247111C2 (enExample)
TR (1) TR200002255T2 (enExample)
WO (1) WO1999040064A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820064A1 (de) 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
AU2000235960A1 (en) * 2000-02-14 2001-08-27 Tularik, Inc. Lxr modulators
AU2001278480A1 (en) 2000-07-24 2002-02-05 Bayer Crop Science Ag Biphenyl carboxamides
AU2003208952B2 (en) 2002-01-30 2008-04-24 Amgen Inc. Heterocyclic arylsulfonamidobenzylic compounds
DE10206354A1 (de) * 2002-02-14 2003-08-28 Aventis Pharma Gmbh Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen
MX2008013194A (es) * 2006-04-11 2008-12-01 Vertex Pharma Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062558A1 (en) * 1991-03-08 1992-09-09 Prasun K. Chakravarty Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
EP0586513A1 (en) * 1991-05-10 1994-03-16 Merck & Co. Inc. Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19741635A1 (de) 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
HUP0102576A1 (hu) 2002-03-28
RU2247111C2 (ru) 2005-02-27
ES2182504T3 (es) 2003-03-01
HU224618B1 (hu) 2005-11-28
EP1053224A1 (de) 2000-11-22
JP2002502840A (ja) 2002-01-29
WO1999040064A1 (de) 1999-08-12
KR100595353B1 (ko) 2006-07-03
PL342453A1 (en) 2001-06-04
HK1034706A1 (en) 2001-11-02
AU3139899A (en) 1999-08-23
AU758154B2 (en) 2003-03-13
DE19804251A1 (de) 1999-08-05
TR200002255T2 (tr) 2001-06-21
DE59902408D1 (de) 2002-09-26
EP1053224B1 (de) 2002-08-21
BR9907667A (pt) 2000-10-24
HUP0102576A3 (en) 2002-12-28
ATE222584T1 (de) 2002-09-15
PT1053224E (pt) 2002-12-31
CN1231465C (zh) 2005-12-14
US6369069B1 (en) 2002-04-09
JP4464559B2 (ja) 2010-05-19
DK1053224T3 (da) 2002-12-23
CA2319555A1 (en) 1999-08-12
KR20010040564A (ko) 2001-05-15
CN1289321A (zh) 2001-03-28

Similar Documents

Publication Publication Date Title
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
AR059505A1 (es) Dihidrodiazepinas utiles como inhibidores de proteina quinasas
AR014974A1 (es) Compuestos con actividad sobre receptores muscarinicos, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de unmedicamento
AR043466A1 (es) Proceso de un solo paso para la preparacion de derivados anticonvulsivos
AR054078A1 (es) Procedimiento para la preparacion de dihidropteridinonas
AR055053A1 (es) Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas.
CO6210724A2 (es) Compuesto heterociclico y composicion farmaceutica del mismo
AR011229A1 (es) Compuestos derivados de adenosina antagonistas en el receptor ai adenosina, procesos para su preparacion, composiciones farmaceuticas que los contieneny su uso en medicina.
AR041941A1 (es) Derivado de 1-aminociclohexano sustituidos en la posicion 4 utilizado como receptor orl1
BR0212760A (pt) Compostos quìmicos
AR037504A1 (es) Derivados de 1,6-naftiridina, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la diabetes y trastornos relacionados
AR036634A1 (es) Composicion de tenido que contiene un compuesto de para-aminofenol o para-fenilen diamina sustituido por un radical silanico
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
AR041883A1 (es) Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
MX9305805A (es) Aroiloxicarboxamidas yodados.
TR200200360T2 (tr) Antibakteriyel aktif maddeler.
NZ505614A (en) Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets
AR040140A1 (es) Derivados de esteres de camptotecina en la posicion 20
ES2167989T3 (es) Derivados del acido 6,8-dimercaptooctanoico substituidos en 6-s y/o 8-s por el radical (3-metiltiopropanoil) y composiciones farmaceuticas destinadas al tratamiento de tumores cancerosos.
AR040139A1 (es) Camptotecinas con un anillo lactona modificado
HUP0104350A2 (hu) Tieno[2,3-d]pirimidin-4-ont tartalmazó szinergetikus fungicid hatóanyag-kompozíció és alkalmazása
DK1042397T3 (da) Stabilisering af siliconeelastomerforme
AR019404A1 (es) Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contiene
AR030194A1 (es) 4-oxo-1,4-dihidro[1,8] naftiridin-3-carboxamidas, composiciones farmaceuticas, el uso de dichos compuestos para preparar un medicamento antiviral y metodo para inhibir la polimerasa adn viral
AR013342A1 (es) Compuesto pseudopeptidos, compuestos intermedios, su preparacion y empleo en formulas farmaceuticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure